4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.09
+0.40 (5.20%)
Jan 22, 2026, 4:00 PM EST - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $462.22 million as of January 22, 2026. Its market cap has increased by 68.61% in one year.
Market Cap
462.22M
Enterprise Value
112.26M
1-Year Change
68.61%
Ranking
Category
Stock Price
$8.09
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $462.22M, a decrease of -20.36%. That is a compound annual growth rate of -4.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 439.37M | 2.53% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 461.73M |
| Eupraxia Pharmaceuticals | 456.87M |
| Vanda Pharmaceuticals | 455.64M |
| NovaBridge Biosciences | 451.94M |
| Anavex Life Sciences | 449.42M |
| Solid Biosciences | 437.86M |
| Absci | 436.08M |
| ADC Therapeutics | 436.05M |